Are monoclonal antibodies effective in patients with severe obesity in SARS‐CoV‐2 infected?

It is important to block SARS‐CoV‐2 infection immediately with early therapies, such as monoclonal antibodies (MonoAbs). Also, several studies show that obesity is associated with a high risk of severe COVID‐19 disease. We enrolled 32 SARS‐CoV‐2 infected patients who received MonoAbs, all patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ucciferri, Claudio, Moffa, Livia, Moffa, Samanta, Vecchiet, Jacopo, Falasca, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910163/
https://www.ncbi.nlm.nih.gov/pubmed/36840489
http://dx.doi.org/10.1002/iid3.771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910163/
https://www.ncbi.nlm.nih.gov/pubmed/36840489
http://dx.doi.org/10.1002/iid3.771

Ejemplares similares